Risk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials

BACKGROUND: Concerns exist regarding the risk of infections in patients with spondyloarthritis (SpA) treated with biologics. We assessed the risk of infections of biological and targeted drugs in patients with SpA by performing a meta-analysis based on randomized controlled trials (RCTs). METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lidong, Man, Siliang, Ji, Xiaojian, Wang, Yiwen, Liu, Xingkang, Zhang, Jiaxin, Song, Chuan, Zhu, Jian, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276457/
https://www.ncbi.nlm.nih.gov/pubmed/35730370
http://dx.doi.org/10.1097/CM9.0000000000001928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276457/
https://www.ncbi.nlm.nih.gov/pubmed/35730370
http://dx.doi.org/10.1097/CM9.0000000000001928

Ejemplares similares